Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Epidermal Growth Factor Receptor (EGFR) (C-Term) Peptid

EGFR Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5671562

Kurzübersicht für Epidermal Growth Factor Receptor (EGFR) (C-Term) Peptid (ABIN5671562)

Target

EGFR (Epidermal Growth Factor Receptor (EGFR))

Spezies

Human

Quelle

  • 17
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Sequenz

    LNPAPSRDPH YQDPHSTAVG NPEYLNTVQP TCVNSTFDSP AHWAQKGSHQ

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti- EGFR Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    EGFR (Epidermal Growth Factor Receptor (EGFR))

    Hintergrund

    The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer.

    Alias Symbols: ERBB, HER1, mENA, ERBB1, PIG61, NISBD2

    Protein Size: 1210

    Gen-ID

    1956

    NCBI Accession

    NM_005228, NP_005219

    UniProt

    P00533
Sie sind hier:
Chat with us!